157 related articles for article (PubMed ID: 7876056)
1. Plasma cell leukemia--report on two cases.
Singh VP; Sundar S; Kumar K; Shukla J; Dube B
J Assoc Physicians India; 1994 Oct; 42(10):824-5. PubMed ID: 7876056
[No Abstract] [Full Text] [Related]
2. Effective cytotoxic treatment of primary plasma cell leukaemia--a report of 3 cases.
Gangadharan VP; Satishkumar K; Pillai R; Cherian V
Acta Oncol; 1994; 33(6):714-5. PubMed ID: 7946458
[No Abstract] [Full Text] [Related]
3. Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia.
Vela-Ojeda J; García-Ruiz Esparza MA; Rosas-Cabral A; Padilla-González Y; García-Chávez J; Tripp-Villanueva F; Sánchez-Cortés E; Ayala-Sánchez M; García-León LD; Montiel-Cervantes L; Rubio-Borja ME
Ann Hematol; 2002 Jul; 81(7):362-7. PubMed ID: 12185504
[TBL] [Abstract][Full Text] [Related]
4. Complete remission in plasma cell leukaemia.
Krsnik I; Peñalver MA; Del Potro E; Diaz-Mediavilla J
Br J Haematol; 1987 May; 66(1):145. PubMed ID: 3593651
[No Abstract] [Full Text] [Related]
5. [Complete double remission and prolonged survival of a patient diagnosed with plasma cell leukemia].
Sureda A; Pérez de Oteyza J; García Laraña J; Odriozola J
Sangre (Barc); 1989 Jun; 34(3):244. PubMed ID: 2762986
[No Abstract] [Full Text] [Related]
6. [Plasma cell leukemia: our experience in 4 cases].
Manso F; Bello JL; Feliu J; García de Bustos J; Losada G; Quevedo E
Rev Clin Esp; 1991 Nov; 189(7):328-30. PubMed ID: 1767090
[TBL] [Abstract][Full Text] [Related]
7. [Plasma cell leukemia induced to complete remission with negative minimal residual disease by qualitative PCR analysis after hyper-CVAD and high-dose melphalan followed by autologous peripheral blood stem cell transplantation].
Hosono N; Yamauchi T; Nakamura T; Yamashita T; Ueda T
Gan To Kagaku Ryoho; 2008 Mar; 35(3):533-7. PubMed ID: 18347412
[TBL] [Abstract][Full Text] [Related]
8. IgE plasma cell leukemia successfully treated with combination VAD (vincristine, doxorubicin, dexamethasone) and MP (melphalan, prednisolone) followed by interferon-alpha.
Yamagata N; Shimazaki C; Goto H; Hirata T; Ashihara E; Oku N; Inaba T; Fujita N; Nakagawa M
Am J Hematol; 1994 Mar; 45(3):262-4. PubMed ID: 8296801
[TBL] [Abstract][Full Text] [Related]
9. [A case of the successful treatment of acute plasmablastic leukemia].
Rekhtina IG; Shchekochikhin SM
Ter Arkh; 1997; 69(11):70-1. PubMed ID: 9483754
[No Abstract] [Full Text] [Related]
10. [Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy].
Shindo T; Yumoto Y; Yoshida M; Okuda T
Rinsho Ketsueki; 2002 Feb; 43(2):107-11. PubMed ID: 11925872
[TBL] [Abstract][Full Text] [Related]
11. Skin lesions in plasmacytoid dendritic cell leukaemia.
Whittle AM; Howard MR
Br J Haematol; 2008 Jan; 140(2):121. PubMed ID: 17991299
[No Abstract] [Full Text] [Related]
12. Primary plasma cell leukemia occuring in the young.
Raj RS; Najeeb S; Aruna R; Pavithran K; Thomas M
Indian J Cancer; 2003; 40(3):116-7. PubMed ID: 14716116
[TBL] [Abstract][Full Text] [Related]
13. Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature.
Hovenga S; de Wolf JT; Klip H; Vellenga E
Bone Marrow Transplant; 1997 Nov; 20(10):901-4. PubMed ID: 9404934
[TBL] [Abstract][Full Text] [Related]
14. [Rheumatoid arthritis and multiple myeloma--the risk of a combination of the 2 diseases].
Lila AM; Mazurov VI; Novik AA
Ter Arkh; 1997; 69(2):50-2. PubMed ID: 9173578
[No Abstract] [Full Text] [Related]
15. [Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV(Ac)P) for multiple myeloma].
Takagi T; Oguro M; Sakai C
Rinsho Ketsueki; 1986 Dec; 27(12):2249-53. PubMed ID: 3471977
[No Abstract] [Full Text] [Related]
16. Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report.
Sajeva MR; Greco MM; Cascavilla N; D'Arena G; Scalzulli P; Melillo L; Minervini MM; Bonini A; Di Mauro L; Carotenuto M; Musto P
Bone Marrow Transplant; 1996 Jul; 18(1):225-7. PubMed ID: 8832022
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and evolutive study of plasma cell leukemia. Apropos of 9 cases].
Panizo Santos C; Cuesta Palomero B; Calasanz Abinzano MJ; Rifón Roca J; Rocha Hernando E
Rev Clin Esp; 1997 May; 197(5):341-5. PubMed ID: 9280968
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia.
Kim SJ; Kim J; Cho Y; Seo BK; Kim BS
Jpn J Clin Oncol; 2007 May; 37(5):382-4. PubMed ID: 17538191
[TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.
Mellqvist UH; Lenhoff S; Johnsen HE; Hjorth M; Holmberg E; Juliusson G; Tangen JM; Westin J;
Cancer; 2008 Jan; 112(1):129-35. PubMed ID: 17973267
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation for plasma cell leukemia following melphalan, cyclophosphamide and total body irradiation.
De Bock R; Nobels F; Schoemaker I; Van der Planken M; Peetermans M
Bone Marrow Transplant; 1989 May; 4(3):331. PubMed ID: 2659119
[No Abstract] [Full Text] [Related]
[Next] [New Search]
